Katherine Wisner, MD member of the WHRI Leadership Council and Director of the Asher Center on Mood Disorders at Northwestern, discussed her role in getting FDA to created a new labeling system regarding drug safety in pregnant women in the Chicago Tribune.  The new guidelines go into effect in June 2015.  Read the article HERE.